Search - tctmd.com

Displaying 661 - 680 of 749

Sort: Relevancy | Date

News Conference News

Next-Generation Devices Address Complications of TAVR

November 08, 2011

News Conference News

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

November 08, 2011

News Industry News

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

November 08, 2011

News Industry News

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

November 08, 2011

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Conference News

TAVR Bioprosthesis Safe, Effective at 1 Year

November 07, 2011

News Industry News

PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions

November 07, 2011

News Industry News

Positive Long Term Clinical Data of the Cappella Sideguard(R) Stent System Announced at TCT 2011

November 07, 2011

News Industry News

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

November 07, 2011

News Industry News

Flexible Stenting Solutions, Inc. Announces First Impant of the 200mm FlexStent Femoropopliteal Self Expanding Stent System

November 07, 2011

News Conference News

EES Associated with Reduced MACE Compared with SES

November 07, 2011

News Industry News

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

November 07, 2011

News Conference News

Stent Grafts Found Effective for SFA Patients with Moderate, Long Lesions

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 03, 2011

News Industry News

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

November 02, 2011

News Industry News

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

November 01, 2011

News Industry News

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

October 31, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

October 06, 2011

Advertisement

Next-Generation Devices Address Complications of TAVR

Mock Jury Votes on DAPT Duration: 12 Months Remains Best Option for Most Patients

Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

TAVR Bioprosthesis Safe, Effective at 1 Year

PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions

Positive Long Term Clinical Data of the Cappella Sideguard(R) Stent System Announced at TCT 2011

Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System

Flexible Stenting Solutions, Inc. Announces First Impant of the 200mm FlexStent Femoropopliteal Self Expanding Stent System

EES Associated with Reduced MACE Compared with SES

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

Stent Grafts Found Effective for SFA Patients with Moderate, Long Lesions

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Abbott to Present New Data for Key Vascular Products at TCT 2011

Arterial Remodeling Technologies (“ART”) reports that its second-generation bioresorbable stent promotes vessel lumen enlargement in post-angioplasty in vivo model

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent

Medtronic Receives First FDA Approval of Cobalt Chromium Balloon-Expandable Stent to Treat Narrowed Iliac Arteries

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content